Publications
Serology-informed estimates of SARS-CoV-2 infection fatality risk in Geneva, Switzerland
Lancet Infect Dis, 2021; 21(4): e69-e70. 10.1016/S1473-3099(20)30584-3
Serological evidence of human infection with SARS-CoV-2: a systematic review and meta-analysis
Lancet Glob Health, 2021; 9(5): e598-e609. 10.1016/S2214-109X(21)00026-7
Comparative Performance of Five Commercially Available Serologic Assays To Detect Antibodies to SARS-CoV-2 and Identify Individuals with High Neutralizing Titers
J Clin Microbiol, 2021; 59(2): e02257-20. 10.1128/JCM.02257-20
Evaluation of Serological SARS-CoV-2 Lateral Flow Assays for Rapid Point-of-Care Testing
J Clin Microbiol, 2021; 59(2): e02020-20. 10.1128/JCM.02020-20
SARS-CoV-2-specific CD8+ T cell responses in convalescent COVID-19 individuals
J Clin Invest, 2021; 131(5): e145476. 10.1172/JCI145476
ABO blood group and SARS-CoV-2 antibody response in a convalescent donor population
Vox Sang, 2021; : . 10.1111/vox.13070
Validation of the Asante HIV-1 Rapid Recency Assay for Detection of Recent HIV-1 Infections in Uganda
AIDS Res Hum Retroviruses, 2021; : . 10.1089/AID.2020.0279
Antibody responses to endemic coronaviruses modulate COVID-19 convalescent plasma functionality
J Clin Invest, 2021; 131(7): e146927. 10.1172/JCI146927
A top scoring pairs classifier for recent HIV infections
Stat Med, 2021; 40(11): 2604-2612. 10.1002/sim.8920
A high prevalence of potential HIV elite controllers identified over 30 years in Democratic Republic of Congo
EBioMedicine, 2021; 65:103258: . 10.1016/j.ebiom.2021.103258
The HIV Screening Cascade: Current Emergency Department-Based Screening Strategies Leave Many Patients With HIV Undiagnosed
J Acquir Immune Defic Syndr, 2021; 87(1): e167-e169. 10.1097/QAI.0000000000002609
Regression with interval-censored covariates: Application to cross-sectional incidence estimation
Biometrics, 2021; : . 10.1111/biom.13472
Differential Performance of CoronaCHEK SARS-CoV-2 Lateral Flow Antibody Assay by Geographic Origin of Samples
J Clin Microbiol, 2021; : . 10.1128/JCM.00837-21
Markers of Polyfunctional SARS-CoV-2 Antibodies in Convalescent Plasma
mBio, 2021; 12(2): e00765-21. 10.1128/mBio.00765-21
Coordinated Strategy for a Model-Based Decision Support Tool for Coronavirus Disease, Utah, USA
Emerg Infect Dis, 2021; 27(5): . 10.3201/eid2705.203075
A scenario modeling pipeline for COVID-19 emergency planning
Sci. Rep., 2021; 11: 7534. 10.1038/s41598-021-86811-0
The Ecology of Nipah Virus in Bangladesh: A Nexus of Land-Use Change and Opportunistic Feeding Behavior in Bats
Viruses, 2021; 13(2): 169. 10.3390/v13020169
Insight into the practical performance of RT-PCR testing for SARS-CoV-2 using serological data: a cohort study
Lancet Microbe, 2021; 2(2): E79-E87. 10.1016/S2666-5247(20)30200-7
Genomic diversity of SARS-CoV-2 during early introduction into the Baltimore–Washington metropolitan area
JCI Insight, 2021; 6(6): e144350. 10.1172/jci.insight.144350
Regional sequencing collaboration reveals persistence of the T12 Vibrio cholerae O1 lineage in West Africa
Elife, 2021; 10: e65159. 10.7554/eLife.65159
The effect of eviction moratoriums on the transmission of SARS-CoV-2
Nat Commun, 2021; 12: 2274. 10.1038/s41467-021-22521-5
Dynamics of COVID-19 under social distancing measures are driven by transmission network structure
PLoS Comput. Biol, 2021; 17(2): e1008684. 10.1371/journal.pcbi.1008684
Mapping the travel patterns of people with malaria in Bangladesh
BMC Med, 2020; 18(1): 45. 10.1186/s12916-020-1512-5
The use of mobile phone data to inform analysis of COVID-19 pandemic epidemiology
Nat Commun, 2020; 11(1): 4961. 10.1038/s41467-020-18190-5
Effect of non-pharmaceutical interventions to contain COVID-19 in Chin
Nature, 2020; 585(7825): 410-413. 10.1038/s41586-020-2293-x
A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity
Nat Commun, 2020; 11(1): 4704. 10.1038/s41467-020-18450-4
Aggregated mobility data could help fight COVID-19
Science, 2020; 368(6487): 145-146. 10.1126/science.abb8021
Deployment of convalescent plasma for the prevention and treatment of COVID-19
J Clin Invest, 2020; 130(6): 2757-2765. 10.1172/JCI138745
Sero-evaluation of Immune Responses to Vibrio cholerae in a Postelimination Setting
Open Forum Infect Dis, 2020; 7(5): ofaa136. 10.1093/ofid/ofaa136
Highly targeted spatiotemporal interventions against cholera epidemics, 2000-19: a scoping review
Lancet Infect Dis, 2020; 21(3): e37-e48. 10.1016/S1473-3099(20)30479-5
From China: hope and lessons for COVID-19 control
Lancet Infect Dis, 2020; 20(7): 756-757. 10.1016/S1473-3099(20)30264-4
Cholera in Haiti - Authors' reply
Lancet Glob Health, 2020; 8(12): e1470-e147. 10.1016/S2214-109X(20)30446-0
The potential impact of COVID-19 in refugee camps in Bangladesh and beyond: A modeling study
PLoS Med, 2020; 17(6): e1003144. 10.1371/journal.pmed.1003144
Serology for SARS-CoV-2: Apprehensions, opportunities, and the path forward
Sci Immunol, 2020; 5(47): eabc6347. 10.1126/sciimmunol.abc6347
Dynamics and significance of the antibody response to SARS-CoV-2 infection
medRxiv, 2020; : . 10.1101/2020.07.18.20155374
The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application
Ann Intern Med, 2020; 172(9): 577-582. 10.7326/M20-0504
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study.
Lancet, 2020; 396(10247): 313-319. 10.1016/S0140-6736(20)31304-0
Age-specific mortality and immunity patterns of SARS-CoV-2
Nature, 2020; 590(7844): 140-145. 10.1038/s41586-020-2918-0
Variation in False-Negative Rate of Reverse Transcriptase Polymerase Chain Reaction-Based SARS-CoV-2 Tests by Time Since Exposure
Ann Intern Med, 2020; 173(4): 262-267. 10.7326/M20-1495
COVID-19 Serology at Population Scale: SARS-CoV-2-Specific Antibody Responses in Saliva
J Clin Microbiol, 2020; 59(1): e02204-20. 10.1128/JCM.02204-20